BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 15579295)

  • 1. Novel markers of oxidative stress in actively progressive HIV dementia.
    Sacktor N; Haughey N; Cutler R; Tamara A; Turchan J; Pardo C; Vargas D; Nath A
    J Neuroimmunol; 2004 Dec; 157(1-2):176-84. PubMed ID: 15579295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Associative and predictive biomarkers of dementia in HIV-1-infected patients.
    Bandaru VV; McArthur JC; Sacktor N; Cutler RG; Knapp EL; Mattson MP; Haughey NJ
    Neurology; 2007 May; 68(18):1481-7. PubMed ID: 17470750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perturbation of sphingolipid metabolism and ceramide production in HIV-dementia.
    Haughey NJ; Cutler RG; Tamara A; McArthur JC; Vargas DL; Pardo CA; Turchan J; Nath A; Mattson MP
    Ann Neurol; 2004 Feb; 55(2):257-67. PubMed ID: 14755730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitrosative stress with HIV dementia causes decreased L-prostaglandin D synthase activity.
    Li W; Malpica-Llanos TM; Gundry R; Cotter RJ; Sacktor N; McArthur J; Nath A
    Neurology; 2008 May; 70(19 Pt 2):1753-62. PubMed ID: 18077799
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of potential antibody markers in HIV-associated dementia.
    Schutzer SE; Berger JR; Brunner M
    J Neuroimmunol; 2004 Dec; 157(1-2):120-5. PubMed ID: 15579288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-1 viral proteins gp120 and Tat induce oxidative stress in brain endothelial cells.
    Price TO; Ercal N; Nakaoke R; Banks WA
    Brain Res; 2005 May; 1045(1-2):57-63. PubMed ID: 15910762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of dopamine in the progression of AIDS Dementia Complex.
    Koutsilieri E; Sopper S; Scheller C; ter Meulen V; Riederer P
    J Neural Transm (Vienna); 2002 Mar; 109(3):399-410. PubMed ID: 11956960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Progressive dementia with seizures in an HIV infected lady.
    James J; Jose J
    Pan Afr Med J; 2017; 27():242. PubMed ID: 28979643
    [No Abstract]   [Full Text] [Related]  

  • 9. Functional imaging of the AIDS dementia complex and the metabolic pathology of the HIV-1-infected brain.
    Navia BA; Gonzalez RG
    Neuroimaging Clin N Am; 1997 Aug; 7(3):431-45. PubMed ID: 9376962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative stress and the HIV-infected brain proteome.
    Uzasci L; Nath A; Cotter R
    J Neuroimmune Pharmacol; 2013 Dec; 8(5):1167-80. PubMed ID: 23475542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-dementia, Tat-induced oxidative stress, and antioxidant therapeutic considerations.
    Pocernich CB; Sultana R; Mohmmad-Abdul H; Nath A; Butterfield DA
    Brain Res Brain Res Rev; 2005 Dec; 50(1):14-26. PubMed ID: 15890409
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A role for spermine oxidase as a mediator of reactive oxygen species production in HIV-Tat-induced neuronal toxicity.
    Capone C; Cervelli M; Angelucci E; Colasanti M; Macone A; Mariottini P; Persichini T
    Free Radic Biol Med; 2013 Oct; 63():99-107. PubMed ID: 23665428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transforming growth factor beta-1 and interferon-alpha in the AIDS dementia complex (ADC): possible relationship with cerebral viral load?
    Perrella O; Carreiri PB; Perrella A; Sbreglia C; Gorga F; Guarnaccia D; Tarantino G
    Eur Cytokine Netw; 2001 Mar; 12(1):51-5. PubMed ID: 11282546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biomarkers of HIV-1 CNS infection and injury.
    Price RW; Epstein LG; Becker JT; Cinque P; Gisslen M; Pulliam L; McArthur JC
    Neurology; 2007 Oct; 69(18):1781-8. PubMed ID: 17967994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evolution of HIV dementia with HIV infection.
    Nath A; Schiess N; Venkatesan A; Rumbaugh J; Sacktor N; McArthur J
    Int Rev Psychiatry; 2008 Feb; 20(1):25-31. PubMed ID: 18240060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of apolipoprotein E on the human immunodeficiency virus protein Tat in neuronal cultures and synaptosomes.
    Pocernich CB; Sultana R; Hone E; Turchan J; Martins RN; Calabrese V; Nath A; Butterfield DA
    J Neurosci Res; 2004 Aug; 77(4):532-9. PubMed ID: 15264223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oxidative stress and therapeutic approaches in HIV dementia.
    Steiner J; Haughey N; Li W; Venkatesan A; Anderson C; Reid R; Malpica T; Pocernich C; Butterfield DA; Nath A
    Antioxid Redox Signal; 2006; 8(11-12):2089-100. PubMed ID: 17034352
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Time course of oxidative events in the hippocampus following intracerebroventricular infusion of quinolinic acid in mice.
    Ganzella M; Jardim FM; Boeck CR; Vendite D
    Neurosci Res; 2006 Aug; 55(4):397-402. PubMed ID: 16766071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection of human immunodeficiency virus induced inflammation and oxidative stress in lenticular nuclei with magnetic resonance spectroscopy despite antiretroviral therapy.
    Roc AC; Ances BM; Chawla S; Korczykowski M; Wolf RL; Kolson DL; Detre JA; Poptani H
    Arch Neurol; 2007 Sep; 64(9):1249-57. PubMed ID: 17620480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell death in HIV dementia.
    Mattson MP; Haughey NJ; Nath A
    Cell Death Differ; 2005 Aug; 12 Suppl 1():893-904. PubMed ID: 15761472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.